Transdermal nicotine and haloperidol in Tourette's disorder: A double-blind placebo-controlled study

Journal of Clinical Psychiatry

Volumn 62, Issue 9, 2001, Pages 707-714

  Silver, A A ^a   Shytle, R D ^a   Philipp, M K ^a   Wilkinson, B J ^a   McConville, B ^a   Sanberg, P R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; MECAMYLAMINE; NICOTINE; PIMOZIDE; PLACEBO;

ABDOMINAL PAIN; ADULT; AKATHISIA; ARTICLE; BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; LETHARGY; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SWEATING; TREATMENT OUTCOME; VERTIGO;

EID: 0034773071     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0908     Document Type: Article

References (41)

1. Pathogenesis of Tourette's syndrome
2. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome
3. Causes of haloperidol discontinuation in patients with Tourette's disorder: Management and alternatives
4. Evidence for the nicotinic cholinergic hypothesis of cannabinoid action within the central nervous system: Extrapyramidal motor behaviors
5. Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders
6. Nicotine potentiates the behavioral effects of haloperidol
7. Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity
8. Nicotine potentiation of haloperidol-induced catalepsy: Striatal mechanisms
9. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome
10. Nicotine gum and haloperidol in Tourette's syndrome
11. Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder
12. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder
13. Nicotine and Tourette's syndrome
14. Tourette's syndrome and nicotine withdrawal
15. Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome
16. Transdermal nicotine in Tourette's syndrome
17. Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: An open study
18. Longlasting improvement of Tourette's syndrome with transdermal nicotine
19. Differential effects of transdermal nicotine patch on the symptoms of Tourette's syndrome
20. Case study: Long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome
21. Transdermal nicotine for Tourette's syndrome
22. Pharmacokinetic considerations in abuse liability evaluation
23. Pharmacology of nicotine: Addiction and therapeutics
24. 2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia
25. Impact of fetal nicotine exposure on development of rat brain regions: Critical sensitive periods or effects of withdrawal?
26. Clinical trials in children and adolescents
27. Clinical experience with transdermal nicotine patch in Tourette's syndrome
28. Cholinergic mechanisms in Tourette syndrome
29. Nicotine, tobacco and addiction
30. The pharmacology of (-)-nicotine and novel cholinergic channel modulators
31. RJR-2403: A nicotinic agonist with CNS selectivity, 2: In vivo characterization
32. Pharmacological characterization of SIB-1765F: A novel cholinergic ion channel agonist
33. Treatment of Tourette's syndrome with mecamylamine
34. Clinical experience with mecamylamine in Tourette syndrome
35. Multicenter double-blind placebo-controlled study of mecamylamine monotherapy for Tourette's disorder
36. Mutually potentiating effects of mecamylamine and haloperidol in producing catalepsy in rats
37. Comorbid bipolar disorder in Tourette syndrome responds to nicotinic receptor antagonist, mecamylamine (Inversine)